Evaluating outcomes of pulsed dye laser therapy combined with intralesional triamcinolone injection after surgical removal of hypertrophic cesarean section scars. (3rd June 2021)

• Record Type: Journal Article
• Authors: Kim, Jee‐Woo; Huh, Chang‐Hun; Na, Jung‐Im; Hong, Joon‐Seok; Yoon Park, Jee; Shin, Jung‐Won
• Is Part Of: Journal of cosmetic dermatology. Volume 21:Number 4(2022)
• Page Start: 1471
• Page End: 1476
• Publication Date: 2021-06-03
• Subjects: cesarean section -- intralesional injection -- keloid -- laser -- scar; Skin -- Diseases -- Treatment -- Periodicals; Lasers in surgery -- Periodicals; Skin -- Pathophysiology -- Periodicals; Surgery, Plastic -- Periodicals; 616.5
• DOI: 10.1111/jocd.14238
• Languages: English
• ISSNs: 1473-2130

Abstract

Abstract: Background: Recently, pulsed dye laser (PDL) combined with triamcinolone intralesional injection (TAILI) has been introduced for surgical scar prevention. However, little is known about this procedure's effectiveness in preventing hypertrophic scar following surgical scar removal. Objectives: This study aimed to evaluate the outcome of early intervention using PDL combined with TAILI after surgical removal of hypertrophic cesarean section (CS) scars. Methods: The medical records of 35 patients who underwent early intervention using PDL and TAILI after removal of hypertrophic CS scars were retrospectively reviewed. The scars' average Vancouver Scar Scale (VSS) scores before scar removal and 3 months after the final treatment were compared. Results: The patients received 4.23 treatments on average and were followed up for a mean period of 7.74 months. The mean final VSS was 3.11 ± 1.52 and was significantly lower than that of the previous VSS (9.29 ± 1.74, p = 0.000). VSS of the previous CS scar, and the presence or absence of keloid formation in other areas, was associated with treatment outcome ( p = 0.003 and 0.008, respectively). Conclusions: Early intervention using PDL combined with TAILI could prevent the recurrence or progression of hypertrophic CS scarring after surgical scar removal.